This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cardinal Health Specialty Solutions, Blue Cross And Blue Shield Of Louisiana Launch Quality Program For Cancer Treatment

BATON ROUGE, La. and DUBLIN, Ohio, Oct. 22, 2012 /PRNewswire/ --  Blue Cross and Blue Shield of Louisiana and Cardinal Health Specialty Solutions have launched a joint program designed to improve cancer treatment using clinical pathways.

The clinical pathways program helps identify and promote best clinical practices in treatment methods for select types of cancer.

"Our goal with this joint program is to work with doctors to improve the consistency, quality and cost-effectiveness of cancer treatment," said David Carmouche, MD, Blue Cross senior vice president and chief medical officer.

Carmouche said that Blue Cross clinical staff will work with oncologists and hematologists throughout the state, combining collaborative dialogue and clinical research with the latest technology—all aimed at encouraging high-quality, evidence-based standards of care to ensure best patient outcomes.

Blue Cross and Cardinal Health Specialty Solutions will establish a committee composed of network oncologists in communities across Louisiana. The committee will identify evidence-based treatment regimens, or clinical pathways, for delivering patient care for breast, colon and lung cancers, among others.

As of the program's launch date, Blue Cross has secured 100 percent participation of community oncologists in the Lafayette, Lake Charles, Monroe, New Orleans and Shreveport markets. Blue Cross network oncologists and hematologists who successfully implement the pathways program may be eligible for rewards and will be noted in the health insurer's searchable online provider directory at

Cardinal Health Specialty Solutions is an independent company that provides technology, education and training to help doctors implement and monitor current and new treatment methods in order to achieve better outcomes. The tools track clinical results and cost savings, while adding little administrative work for the oncologists and hematologists who participate.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs